Search Within

Fiyinfolu Oladele Balogun

Formats
  1. Meeting Abstract (9)
  2. Journal Article (5)
  3. Editorial (1)
Groups
  1. Center for Pancreatic Cancer Research (13)
  2. Department of Medicine (13)
  3. Gastrointestinal Oncology Service (13)
  4. Solid Tumor Oncology Division (13)
  5. Survivorship Research (13)
  6. CTCR Scholars (12)

More Groups

People
  1. Eileen O'Reilly (12)
  2. Wungki Park (12)
  3. Anna Varghese (11)
  4. Catherine O'Connor (11)
  5. Kenneth Yu (11)
  6. Joanne Chou (10)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (6)
  4. 2022 (3)
Publications
  1. Journal of Clinical Oncology (7)
  2. Annals of Oncology (2)
  3. JAMA Oncology (2)
  4. JNCI: Journal of the National Cancer Institute (2)
  5. Clinical Cancer Research (1)
  6. JCO Global Oncology (1)
Publishers
  1. American Society of Clinical Oncology (8)
  2. Oxford University Press (4)
  3. American Medical Association (2)
  4. American Association for Cancer Research (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: Clinical insights and genomic features from a large contemporary cohort
    Journal Article

    Keane, F.; O’Connor, C.; Moss, D.; Chou, J. F.; Perry, M. A.; Crowley, F.; Saxena, P.; Chan, A.; Schoenfeld, J. D.; Singhal, A.; more...
    JNCI: Journal of the National Cancer Institute (2025)

    Fulltext@MSK | Save
  • Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J.; Schwartz, C.; Larsen, M.; Varghese, A.; Yu, K.; Balogun, F.; Yang, J.; Katz, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Lynch syndrome and somatic mismatch repair variants in pancreas cancer
    Journal Article

    O'Connor, C. A.; Harrold, E.; Lin, D.; Walch, H.; Gazzo, A.; Ranganathan, M.; Kane, S.; Keane, F.; Schoenfeld, J.; Moss, D.; more...
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • Precision medicine for pancreatic cancer: Characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease
    Journal Article

    Keane, F.; Chou, J. F.; Walch, H.; Schoenfeld, J.; Singhal, A.; Cowzer, D.; Harrold, E.; O'Connor, C. A.; Park, W.; Varghese, A.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes
    Meeting Abstract

    Keane, F.; Moss, D.; O'Connor, C. A.; Perry, M.; Chou, J. F.; Crowley, F.; Saxena, P.; Chan, A.; Park, W.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Somatic mismatch repair deficiency in pancreas cancer (PC): Immune checkpoint blockade (ICB) outcomes and exploratory genomic analyses
    Meeting Abstract

    O'Connor, C. A.; Harrold, E.; Lin, Y. T.; Walch, H. S.; Gazzo, A.; Kane, S. R.; Keane, F.; Schoenfeld, J. D.; Moss, D.; Suehnholz, S. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Africa guidelines for hepatocellular carcinoma buildup process
    Journal Article

    Abou-Alfa, G. K.; Afihene, M.; Capanu, M.; Li, Y.; Chou, J. F.; Asombang, A.; Alatise, O. I.; Bounedjar, A.; Cunha, L.; Mekonnen, H. D.; more...
    JCO Global Oncology (2023)

    Fulltext@MSK | Save
  • The Onc Docs: Partnering with Black cancer patients for cancer education
    Meeting Abstract

    Balogun, F.; Balogun, O.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Meeting Abstract

    Keane, F.; Saadat, L.; O'Connor, C.; Chou, J. F.; Brannon, A. R.; Cowzer, D.; Crowley, F.; Debnath, N.; Bowman, A.; Xu, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save